Empresa Institute of Biomedical Research Corp. Other OTC
Acciones
MRES
US45781A1079
Ventas por actividad
USD en millones | 2014 | Peso | 2015 | Peso | Delta |
---|---|---|---|---|---|
Alternative Plant-based Cannabinoids and Mental hHalth Therapeutic Research
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +24,68 % |
Ventas por región
USD en millones | 2014 | Peso | 2015 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +24,68 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Peter Robinson
CEO | Chief Executive Officer | - | 11/07/22 |
Willem Jonker
DFI | Director of Finance/CFO | 66 | - |
Chief Tech/Sci/R&D Officer | - | - | |
Marko Maljkovic
SAM | Sales & Marketing | - | - |
Zeljko Jacimovic
PRN | Corporate Officer/Principal | - | - |
Momir Mikov
PRN | Corporate Officer/Principal | - | - |
Veselin Delevic
PRN | Corporate Officer/Principal | - | - |
Richard Morisset
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | - | |
Peter Robinson
CEO | Chief Executive Officer | - | 11/07/22 |
Willem Jonker
DFI | Director of Finance/CFO | 66 | - |
Información de la empresa
Institute of BioMedical Research Corp.
Jele Andrijasevic 2 Niksic
81004, Niksic
+
http://www.mrescorp.com